Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

DARK SECRETS: Ubs just upgraded argenx stock heres why - The Real Truth

Argenx (ARGX) stock pushed higher on Aug. 26 after UBS issued a bullish note in favor of the biotech firm, citing a stronger outlook for its flagship Vyvgart franchise. Analyst Xian Deng upgraded ARGX this morning to “Buy” and raised her price target significantly to $1,400, indicating potential upside of about 37% from current levels.

Note that Argenx shares have already been a blockbuster investment for 2026, currently up more than 50% versus their year-to-date low.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.